ARE Patent Litigation Alert:
Centillion v. Qwest Communications: Federal Circuit Held That “Use” of a System Means Use as a Whole and the User Must Derive Benefit From It

(January 31, 2011) In Centillion Data Systems, LLC v. Qwest Communications Int’l, Inc., 2010-1110 (Fed. Cir. January 20, 2011), the Federal Circuit addressed the issue of what constitutes “use” of a system under 35 U.S.C. § 271(a), in what the panel recognized to be a case of first impression for the court. Centillion interpreted the […]

ARE Patent Litigation Alert:
Uniloc USA v. Microsoft: Federal Circuit Held the 25% Rule of Thumb By Damages Expert is a Fundamentally Flawed Tool for Determining a Baseline Royalty Rate In Patent Damages Analysis

On January 4, 2011, the U.S. Court of Appeals for the Federal Circuit held in Uniloc USA Inc. et al. v. Microsoft Corp. et al., 2010-1035 (Fed. Cir. January 4, 2011) that the 25% “rule of thumb” often used by patent damages experts is a fundamentally flawed tool for determining a baseline royalty rate in […]

ARE Patent Litigation Alert: Uniloc USA v. Microsoft: Federal Circuit Held the 25% Rule of Thumb By Damages Expert is a Fundamentally Flawed Tool for Determining a Baseline Royalty Rate In Patent Damages Analysis

On January 4, 2011, the U.S. Court of Appeals for the Federal Circuit held in Uniloc USA Inc. et al. v. Microsoft Corp. et al., 2010-1035 (Fed. Cir. January 4, 2011) that the 25% “rule of thumb” often used by patent damages experts is a fundamentally flawed tool for determining a baseline royalty rate in […]

ARE Patent Litigation Alert:
Federal Circuit Turns Its Attention to Natural Phenomena Under 35 U.S.C. § 101

On December 17, 2010, the U.S. Court of Appeals for the Federal Circuit issued an Opinion and Order confirming the patent-eligibility of claims directed to methods used in treating gastrointestinal and non-gastrointestinal autoimmune diseases in Prometheus Laboratories, Inc. v. Mayo Collaborative Services, No. 2008-1403 (Fed. Cir. Dec. 17, 2010). The district court in Prometheus granted […]

ARE Patent Litigation Alert: Federal Circuit Turns Its Attention to Natural Phenomena Under 35 U.S.C. § 101

On December 17, 2010, the U.S. Court of Appeals for the Federal Circuit issued an Opinion and Order confirming the patent-eligibility of claims directed to methods used in treating gastrointestinal and non-gastrointestinal autoimmune diseases in Prometheus Laboratories, Inc. v. Mayo Collaborative Services, No. 2008-1403 (Fed. Cir. Dec. 17, 2010). The district court in Prometheus granted […]